help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0112
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Charmandari, E.
Right arrow Articles by Kino, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charmandari, E.
Right arrow Articles by Kino, T.
Molecular Endocrinology 19 (1): 52-64
Copyright © 2005 by The Endocrine Society

The Human Glucocorticoid Receptor (hGR) ß Isoform Suppresses the Transcriptional Activity of hGR{alpha} by Interfering with Formation of Active Coactivator Complexes

Evangelia Charmandari, George P. Chrousos, Takamasa Ichijo, Nisan Bhattacharyya, Alessandra Vottero, Emmanuil Souvatzoglou and Tomoshige Kino

Pediatric and Reproductive Endocrinology Branch (E.C., G.P.C., T.I., A.V., T.K.), National Institute of Child Health and Human Development, and Diabetes Branch (N.B.), National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Evangelia Charmandari, MD, Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Drive, Building 10, Room 9D42, Bethesda, Maryland 20892-1583. E-mail: charmane{at}mail.nih.gov.

The human glucocorticoid receptor (hGR) ß, a splicing variant of the classic receptor hGR{alpha}, functions as a dominant-negative inhibitor of hGR{alpha}. We explored the mechanism(s) underlying this effect of hGRß by evaluating the interactions of this isoform with known steroid receptor coactivators. We found that hGRß suppressed the transcriptional activity of both activation function (AF)-1 and AF-2 of hGR{alpha}, indicating that hGRß may exert its dominant-negative effect by affecting the function of coactivators that are attracted to these transactivation domains. hGRß bound to one of the p160 coactivators, the glucocorticoid receptor-interacting protein 1 (GRIP1) via its preserved AF-1 but not via its defective AF-2 in vitro. In a chromatin immunoprecipitation assay, hGRß prevented coprecipitation of GRIP1 with hGR{alpha} tethered to glucocorticoid response elements of the endogenous tyrosine aminotransferase promoter, whereas deletion of the AF-1 of hGRß abolished this effect. In further experiments, overexpression of GRIP1 attenuated the suppressive effect of hGRß on hGR{alpha}-mediated transactivation of the mouse mammary tumor virus promoter. Competition for binding to glucocorticoid response elements or heterodimerization with hGR{alpha} via the D loop dimerization interface occurred, but they were not necessary for the suppressive effect of hGRß on the transcriptional activity of hGR{alpha}. Our findings suggest that hGRß suppresses the transcriptional activity of hGR{alpha} by competing with hGR{alpha} for binding to GRIP1, and possibly other p160 coactivators, through its preserved AF-1. These findings suggest that participation of hGRß in the formation of a coactivator complex renders this complex ineffective.

NURSA Molecule Pages Link:

Nuclear Receptors:   GR
Coregulators:   GRIP1
Ligands:   Dexamethasone



This article has been cited by other articles:


Home page
IOVSHome page
I. V. Glybina, A. Kennedy, P. Ashton, G. W. Abrams, and R. Iezzi
Photoreceptor Neuroprotection in RCS Rats via Low-Dose Intravitreal Sustained-Delivery of Fluocinolone Acetonide
Invest. Ophthalmol. Vis. Sci., October 1, 2009; 50(10): 4847 - 4857.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, T. Ichijo, W. Jubiz, S. Baid, K. Zachman, G. P. Chrousos, and T. Kino
A Novel Point Mutation in the Amino Terminal Domain of the Human Glucocorticoid Receptor (hGR) Gene Enhancing hGR-Mediated Gene Expression
J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4963 - 4968.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Kamiyama, N. Matsuda, S. Yamamoto, K.-i. Takano, Y. Takano, H. Yamazaki, S.-i. Kageyama, H. Yokoo, T. Nagata, N. Hatakeyama, et al.
Modulation of glucocorticoid receptor expression, inflammation, and cell apoptosis in septic guinea pig lungs using methylprednisolone
Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L998 - L1006.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Nehme and J. Edelman
Dexamethasone Inhibits High Glucose-, TNF-{alpha}-, and IL-1{beta}-Induced Secretion of Inflammatory and Angiogenic Mediators from Retinal Microvascular Pericytes
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2030 - 2038.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. J. M. Schaaf, D. Champagne, I. H. C. van Laanen, D. C. W. A. van Wijk, A. H. Meijer, O. C. Meijer, H. P. Spaink, and M. K. Richardson
Discovery of a Functional Glucocorticoid Receptor {beta}-Isoform in Zebrafish
Endocrinology, April 1, 2008; 149(4): 1591 - 1599.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L.-b. Li, D. Y. M. Leung, M. J. Strand, and E. Goleva
ATF2 impairs glucocorticoid receptor mediated transactivation in human CD8+ T cells
Blood, September 1, 2007; 110(5): 1570 - 1577.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Kino, T. Ichijo, N. D. Amin, S. Kesavapany, Y. Wang, N. Kim, S. Rao, A. Player, Y.-L. Zheng, M. J. Garabedian, et al.
Cyclin-Dependent Kinase 5 Differentially Regulates the Transcriptional Activity of the Glucocorticoid Receptor through Phosphorylation: Clinical Implications for the Nervous System Response to Glucocorticoids and Stress
Mol. Endocrinol., July 1, 2007; 21(7): 1552 - 1568.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. L. Kozaci, Y. Chernajovsky, and I. C. Chikanza
The differential expression of corticosteroid receptor isoforms in corticosteroid-resistant and -sensitive patients with rheumatoid arthritis
Rheumatology, April 1, 2007; 46(4): 579 - 585.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L.-b. Li, D. Y. M. Leung, C. F. Hall, and E. Goleva
Divergent expression and function of glucocorticoid receptor {beta} in human monocytes and T cells
J. Leukoc. Biol., April 1, 2006; 79(4): 818 - 827.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. Goleva, L.-b. Li, P. T. Eves, M. J. Strand, R. J. Martin, and D. Y. M. Leung
Increased Glucocorticoid Receptor beta Alters Steroid Response in Glucocorticoid-insensitive Asthma
Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 607 - 616.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
G. P. Chrousos and T. Kino
Intracellular Glucocorticoid Signaling: A Formerly Simple System Turns Stochastic
Sci. Signal., October 4, 2005; 2005(304): pe48 - pe48.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. D Turner and C. P Muller
Structure of the glucocorticoid receptor (NR3C1) gene 5' untranslated region: identification, and tissue distribution of multiple new human exon 1
J. Mol. Endocrinol., October 1, 2005; 35(2): 283 - 292.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Russcher, E. F. C. van Rossum, F. H. de Jong, A. O. Brinkmann, S. W. J. Lamberts, and J. W. Koper
Increased Expression of the Glucocorticoid Receptor-A Translational Isoform as a Result of the ER22/23EK Polymorphism
Mol. Endocrinol., July 1, 2005; 19(7): 1687 - 1696.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, A. Raji, T. Kino, T. Ichijo, A. Tiulpakov, K. Zachman, and G. P. Chrousos
A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3696 - 3705.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society